75 reports

Global Cancer Immunotherapy Market Forecast 2019-2029 ##.

  • Cancer Immunotherapy
  • Therapy
  • World
  • Market Size

Global Cancer Immunotherapy Market to 2027 ##.

  • Cancer Immunotherapy
  • Therapy
  • World
  • Market Size

##.

  • Cancer Immunotherapy
  • Therapy
  • World
  • Market Size

The global market value for cancer immunotherapy was estimated using these three different approaches and was validated against one another.

  • Cancer Immunotherapy
  • Therapy
  • World
  • Market Size

Global Cancer Immunotherapy Market (2018 - 2024) Global Cancer Immunotherapy Market: Chapter ##.

  • Cancer Immunotherapy
  • Therapy
  • North America
  • United States
  • Market Size
  • CANCER IMMUNOTHERAPY ARTIFICIAL INTELLIGENCE MARKET SHARES,
  • CANCER IMMUNOTHERAPY ARTIFICIAL INTELLIGENCE SYSTEMS, REGIONAL

At Memorial Sloan Kettering, immunotherapy is one of the most promising ways to treat, cure, and ultimately prevent cancer. Immunotherapy

  • Cancer Immunotherapy
  • Foundation Medicine, Inc.
  • GE Healthcare Limited
  • General Electric Company
  • NVIDIA Corporation

## List of Strategic Partnerships TABLE ## Gap analysis: Cancer immunotherapy drug discovery outsourcing services TABLE ## North America cancer immunotherapy drug discovery outsourcing market, by drug type, 2014 - 2025 (USD Million) TABLE ## North America

  • Cancer Immunotherapy
  • Therapy
  • United States
  • Forecast

Europe Cancer Immunotherapy Market (2018 - 2024) Europe Cancer Immunotherapy Market: Chapter ##.

  • Cancer Immunotherapy
  • Therapy
  • Europe
  • United States
  • Market Size

Asia Pacific Cancer Immunotherapy Market (2018 - 2024) Asia Pacific Cancer Immunotherapy Market: Chapter ##.

  • Cancer Immunotherapy
  • Therapy
  • APAC
  • United States
  • Market Size

North America Cancer Immunotherapy Market (2018 - 2024) North America Cancer Immunotherapy Market: Chapter ##.

  • Cancer Immunotherapy
  • Therapy
  • North America
  • United States
  • Market Size

Latin America, Middle East & Africa Cancer Immunotherapy Market (2018 - 2024) LAMEA Cancer Immunotherapy Market: Chapter ##.

  • Cancer Immunotherapy
  • Oncology
  • Therapy
  • United States
  • Market Size

Global Cancer Immunotherapy Market & Clinical Trials Outlook 2022 ##.

  • Cancer Immunotherapy
  • Medical Biotechnology
  • Therapy
  • World

Cancer Immunotherapy Market - Global Opportunity Analysis and Industry Forecast, 2014-2022 CHAPTER ## INTRODUCTION ##. ##.

  • Cancer Immunotherapy
  • Therapy
  • World
  • Market Size

LAMEA Cancer Immunotherapy MarketAnalysis (2017-2023) Chapter ##.

  • Cancer Immunotherapy
  • Oncology
  • Therapy
  • United States
  • Market Size

The drug candidate acts by targeting indoleamine ##, ##-dioxygenase-## (IDO-##).

  • Cancer
  • Cancer Immunotherapy
  • Immunotherapy
  • Specialty Hospital
  • Therapy

Global Dendritic Cell Cancer Vaccine Market & Clinical Trials Outlook 2023 ##.

  • Cancer Immunotherapy
  • Cell Therapy
  • Medical Biotechnology
  • Therapy
  • World

Global Cancer Immunotherapies Market to 2024 - Increased Uptake of Immune Checkpoint Inhibitors Driving Growth, Supported by a Large, Robust Pipeline ## Table of Contents ## ##. ## List of Tables ## ##. ## List of Figures ## ## Introduction ## ##. ## Therapy Area Introduction ## ##. ## Overview of

  • Cancer Immunotherapy
  • Therapy
  • Company Financials
  • Parker Institute for Cancer Immunotherapy - Locations And Subsidiaries
  • Parker Institute for Cancer Immunotherapy - Key Employees

The company' s deal volume increased from one pharmaceuticals & healthcare deal in 2016 to four pharmaceuticals & healthcare deals in 2017.

  • Cancer Immunotherapy
  • Healthcare
  • Pharmaceutical
  • Therapy
  • United States

Personalized Vaccine: Trail Towards Cancer ##. ## Prologue to Personalized Cancer Immunotherapy ##. ## Advent of Personalized Cancer Vaccine ##.

  • Cancer Immunotherapy
  • Therapy
  • Vaccine
  • Cancer Immunotherapies, Global, Pipeline Products,
  • Cancer Immunotherapies, Licensing Deals with

Targeting PD-##/ PD-L## interactions for cancer immunotherapy.

  • Cancer Immunotherapy
  • Immunotherapy
  • Monoclonal Antibody
  • Oncology
  • Therapy
  • Nov 27, 2017: Inovio Pharmaceuticals SynCon TERT Cancer Immunotherapy Combined with Checkpoint Inhibitor Synergistically Shrinks Tumor and Improves Survival in Preclinical Tumor Model
  • Sep 11, 2017: Inovios Cancer Immunotherapy (INO-5150) Slowed PSA Rise and Significantly Increased PSA Doubling Times In Patients with Recurrent Prostate Cancer

The objective is to improve the breadth and effectiveness of a prostate cancer immunotherapy.

  • Cancer Immunotherapy
  • Medical Biotechnology
  • United States
  • Product Initiative
  • Inovio Pharmaceuticals, Inc.
  • VACCINE TO TARGET MUC-1 FOR ONCOLOGY - DRUG PROFILE
  • PIPELINE BY AKSHAYA BIO INC, H1 2019

JUL ##, 2017: CANCER IMMUNOTHERAPY COMPANY VAXIL APPOINTS DR.

  • Cancer
  • Cancer Immunotherapy
  • Vaccine
  • United States
  • Product Initiative
  • Nov 27, 2017: Inovio Pharmaceuticals SynCon TERT Cancer Immunotherapy Combined with Checkpoint Inhibitor Synergistically Shrinks Tumor and Improves Survival in Preclinical Tumor Model
  • INO-5401 - Drug Profile

WT## has been a focus of cancer vaccine researchers since the National Cancer Institute ranked it as the number one priority target for cancer immunotherapy.

  • Cancer Immunotherapy
  • Pharmaceutical
  • Therapy
  • Vaccine
  • SELLAS Life Sciences Group
  • Jan 02, 2018: Compugen Announces Presentations at Three Upcoming Cancer Immunotherapy Conferences
  • Oct 09, 2017: A New Immunomodulatory Target Discovered by Compugen Demonstrates Potential for First-in-Class Cancer Therapy

As we believe we have the only clinical-stage product candidate targeting PVRIG, which is part of the larger TIGIT/ PVRIG and PD-## axis, Compugen has a first-mover advantage in the competitive cancer immunotherapy landscape. "

  • Cancer Immunotherapy
  • Immunotherapy
  • United States
  • Company
  • Compugen Ltd.
  • GEOCM-01 - DRUG PROFILE
  • PIPELINE BY AKSHAYA BIO INC, H2 2018

JUL ##, 2017: CANCER IMMUNOTHERAPY COMPANY VAXIL APPOINTS DR.

  • Cancer Immunotherapy
  • Oncology
  • Therapy
  • Vaccine
  • Vaxil
  • RISE IN COSTS OF CANCER IMMUNOTHERAPY DRUGS
  • GLOBAL CANCER IMMUNOTHERAPY DRUGS MARKET SIZE FOR MALIGNANT TUMORS, BY REGION, 2014-2021 (USD BILLION)

(Switzerland). ## ##. ##. ## U.

  • Cancer
  • Cancer Immunotherapy
  • North America
  • United States
  • World
  • TRANBERG CANCER IMMUNOTHERAPY SYSTEM - SKIN CANCER
  • CLS CANCER IMMUNOTHERAPY SYSTEM - PROSTATE CANCER

Thereafter UTMB placed one additional order for single use products.

  • Cancer Immunotherapy
  • Clinical Trial
  • Magnetic Resonance Imaging
  • Prostate Cancer
  • Therapy
  • collaboration were not disclosed.
  • FLX-475 - DRUG PROFILE

The trial will be conducted as part of MORPHEUS, Roche' s cancer immunotherapy development platform.

  • Cancer
  • Cancer Immunotherapy
  • Monoclonal Antibody
  • Therapy
  • United States
  • Apr 04, 2017: Unprecedented 5-year follow-up shows long-term survival in lung cancer

The TILs, which are essentially cancer killing cells, are then infused back into the patient intravenously to find and destroy the cancer. " Immunotherapy

  • Cancer Immunotherapy
  • Lung Cancer
  • Pharmaceutical
  • Therapy
  • Ono Pharmaceutical Co., Ltd.
  • Pipeline by Akshaya Bio Inc, H1 2019
  • Based Cancer Vaccine .

Etubics' CEA product for colon cancer immunotherapy.

  • Cancer Immunotherapy
  • Medical Biotechnology
  • Monoclonal Antibody
  • Therapy
  • Etubics Corporation